Therapeutics (TGTX) 2025 Earnings Outlook for Investors
TG Therapeutics faces a pivotal year as it closes 2025 with a tighter focus on its flagship therapeutics portfolio an...
Explore various work from home opportunities that can help you earn quick cash. Find flexible options that fit your schedule.
23,704 articlesTG Therapeutics faces a pivotal year as it closes 2025 with a tighter focus on its flagship therapeutics portfolio an...
IREN is positioning itself as a key AI infrastructure partner as demand for GPU compute grows. This article explores ...
Broadcom reported a strong Q1 FY2026 with AI-driven growth and a deep backlog, setting up a targeted, three-year broa...
GM is rebooting its U.S. investment strategy with tighter budgets and sharper priorities. This move aims to boost nea...
New disclosures reveal a large, ongoing cash burn tied to Elon Musk’s AI push, exposing capital risks for SpaceX-xAI ...
Amazon delivered strong AWS growth and solid Q1 results, but a large capex plan keeps investors wary. Still, a broad ...
Stellantis faces a pivotal push to revive overseas markets and lift investor confidence. This deep-dive explores the ...
A popular fallen angel ETF delivers about 6% yield paid monthly by buying bonds downgraded from investment grade. It’...
Unlock a practical, investor-friendly view of arbor realty (abr) earnings. Learn what drives ABR earnings, how to int...
Fresh insider purchases in three battered names point to growing belief that cash flow and demand visibility can rebo...
Red Cat Holdings posted a record Q4 revenue of $26.2 million and full-year $40.7 million, but margins stayed thin and...
Coca-Cola and Philip Morris International both beat expectations in Q1 2026 and now sit near 52-week highs. Analysts ...